Sophia Genetics SA (NAS:SOPH)
$ 4.73 -0.01 (-0.21%) Market Cap: 309.22 Mil Enterprise Value: 222.93 Mil PE Ratio: 0 PB Ratio: 2.34 GF Score: 40/100

Sophia Genetics SA at Barclays Global Healthcare Conference Transcript

Mar 14, 2023 / 07:33PM GMT
Release Date Price: $4.99 (+37.47%)
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

All right. Good afternoon, everybody. Luke Sergott, I cover life sciences tools and diagnostics here at Barclays. I have with me Jurgi, CEO of SOPHiA GENETICS. Thank you again for making. We're just talking to you -- your third time or at least being interviewed by me, second time at Barclays. So I guess what we can start here is, if you want to take a couple of minutes and go to the overview of the business and really what I want you to think about is how the business has changed over the last 12 to 18 months since you were here last time. And really the trajectory that you guys have going over for the next 2 to 3 years and the groundwork that you've laid and really kind of how you're expecting that to really flow through.

Jurgi Camblong
SOPHiA GENETICS SA - Co-Founder, CEO & Director

Sure. So it's a good question. And as you know, we went public in July 2021, right? And back then, there were kind of some questions about SOPHiA as well. And I think we've been able to answer to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot